|Titre :||Druglink, Vol.29, n°4 - July-August 2014 - Future tense. What will the drivers for investment be going forward?|
|Type de document :||Bulletin : Périodique|
|Paru le :||01/08/2014|
|Année de publication :||2014|
|Format :||30 p.|
|Note de contenu :||
Are synthetic cannabinoids the new heroin?
New York Times backs cannabis legalisation
EU rule against medicines control of NPS
Obituary: David Turner, 1949-2014
- The futures market: Marcus Roberts considers an analysis of the interplay between crime, heroin and poverty in the past - and what it may look like in the future.
- Driven by loss: Three parents whose children died after taking drugs talk to Max Daly about how their grief has driven a desire to take action.
- Crime-Busters or PCC Plods? According to former detective sergeant Geoff Monaghan, most Police and Crime Commissioners are not hitting the mark.
- NICE of you to notice: Are users of image and performance-enhancing drugs finally getting the help they need? Joseph Kean and Jim McVeigh weigh up the evidence.
- Scary monsters: Neil McKeganey asks if public health practitioners are starting a new moral panic over e-cigarettes.
- TEN... and you're out: Unlicensed raves are popping up all over the UK. Peggy Whitfield examines why some promoters are choosing to go down the illegal route.
- Joint ventures: Medical and recreational marijuana is now big business in North America. David Ader takes a look at the new economy of pot.
- Drug and Alcohol Findings: What do the patients want? The Findings team analyse what policymakers mean by 'patient-centred care' and the implications for the drug and alcohol sector.
DépouillementsAjouter le résultat dans votre panier
Article : Périodique
Etizolam is a benzodiazepine analogue. It has gathered some popularity on the new psychoactive substance (NPS) market in the UK and Europe. It has a broadly similar pharmacological profile to benzodiazepine drugs such as diazepam. A 1mg tablet i[...]